TABLE 3.
Complementation of morphology by mosaic and mutant PBPsa
Protein or plasmid | Sequences around KTG motif
|
Complementationb | ||
---|---|---|---|---|
197-203 | 204-219 | 220-228 | ||
Proteins | ||||
PBP 5 | NRNGLLW | DNSLNVDGIKTGHTDK | AGYNLVASA | |
PBP 6 | NRNRLLW | SSNLNVDGMKTGTTAG | AGYNLVASA | |
DacD | NRNGLLW | DKTMNVDGLKTGHTSG | AGFNLIASA | |
pAG656-11 derivativesc | ||||
pAG656-11 | NRNGLLW | DNSLNVDGIKTGHTDK | AGYNLVASA | + |
pAG656-X2A | NRNRLLW | DNSLNVDGIKTGHTDK | + | |
pAG656-M1A | DSSLNVDGIKTGHTDK | + | ||
pAG656-M2A | DNNLNVDGIKTGHTDK | + | ||
pAG656-M3A | DNSLNVDGMKTGHTDK | + | ||
pAG656-H | DNSLNVDGIKTGTTDK | + | ||
pAG656-M4A | DNSLNVDGIKTGHTAK | − | ||
pAG656-M11A | DNSLNVDGIKTGHTDG | − | ||
pAG656-M5A | DNSLNVDGIKTGHTAG | − | ||
pAG565-3 derivativesd | ||||
pAG565-3 | NRNRLLW | SSNLNVDGMKTGTTAG | AGYNLVASA | − |
pAG565-X1A | NRNGLLW | SSNLNVDGMKTGTTAG | − | |
pAG565-M6Ae | SNNLNEDGMKTGTTAG | − | ||
pAG565-M7Ae | SSSLNEDGIKTGTTAG | − | ||
pAG565-T | SSNLNVDGMKTGHTAG | − | ||
pAG565-M9A | SSNLNVDGMKTGTTDG | + | ||
pAG565-M10A | SSNLNVDGMKTGTTAK | + | ||
pAG565-X5B | NRNRLLW | SSNLNVDGMKTGTTAG | − | |
pAG565-X6A | NRNGLLW | SSNLNVDGMKTGTTAG | − | |
pPJ5 derivativesf (full-length PBP 5 and mutants): | ||||
pPJ5 | NRNGLLW | DNSLNVDGIKTGHTDK | AGYNLVASA | + |
pPJ5-DK/AG | DNSLNVDGIKTGHTAG | + | ||
pAG5-X3A | NRNRLLW | DNSLNVDGIKTGHTDK | + | |
pAG5-X4A | NRNRLLW | DNSLNVDGIKTGHTAG | + | |
pPJ5-T217A | DNSLNVDGIKTGHADK | + | ||
pPJ5-K213E | DNSLNVDGIETGHTDK | − | ||
pPJ5-K213R | DNSLNVDGIRTGHTDK | − |
Residue numbers refer to the mature protein and correspond to the numbering system used in the crystal structure of PBP 5 (9). Amino acids that differ from the sequence of PBP 5 are boldfaced and double underlined. The KTG active site motif is underlined once in the first sequence. Residues that are boldfaced and double underlined indicate differences from the first sequence shown in each section. For clarity, the sequence of residues 197 to 203 and 220 to 228 were omitted from the table when these were identical to the first sequence in each section. The inserted genes in each plasmid were sequenced to confirm that no other alterations were present. The sequences of the primer pairs used to create each mutant can be inferred from the amino acid alterations, but these are also available on request.
Effect of plasmid-encoded proteins on the cellular morphology of E. coli CS701-1 or CS703-1: +, complete or virtually complete restoration of uniform wild-type rod-shaped morphology; −, little or no restoration of uniform wild-type rod-shaped morphology.
These derivatives had PBP 5 residues 200 to 219 inserted into PBP 6, and thus the residues listed in the 204-219 column are from PBP 5.
These derivatives had PBP 6 residues 200 to 219 inserted into PBP 5, and thus the residues listed in the 204-219 column are from PBP 6. The residue at position 141 was D in all these derivatives except the last two, in which it was G. The G141D mutation was present in plasmid pAG565-3 and several of its derivatives. However, this mutation did not affect the complementation properties of the PBP mosaic proteins (compare the results for pAG565-3 with those for pAG565-X5B and pAG565-X6A).
The glutamic acid residue (E) at position 209 in pAG565-M6A and pAG565-M7A is present in the E. coli K-12 genomic sequence (6), but a valine residue (V) is present in E. coli O157:H7 (15) and in the parental E. coli strain CS109 used in this work. Thus, PBP 5 with either glutamic acid or valine in this position has wild-type properties.
These derivatives had full-length PBP 5 with various mutations.